The Food and Drug Administration (FDA) says abortion providers are prescribing abortion-inducing drugs to women in advance of becoming pregnant – a practice that is without authorization and potentially dangerous for women.
“The FDA is concerned about the advance prescribing of mifepristone for this use,” an anonymous FDA spokesperson reportedly told the German-owned Politico Friday. “Mifepristone is not approved for advance provision of a medical abortion.”
A new study reveals that women and girls who use drugs to induce abortions are exposed to increased health risks when they suffer complications, including admissions for surgeries and further hospital admissions, when they deceive doctors by saying they have suffered a “natural miscarriage” instead of having chosen a drug-induced abortion.
Last week, the Charlotte Lozier Institute (CLI), the research arm of Susan B. Anthony Pro-Life America, released the study, titled “A Post Hoc Exploratory Analysis: Induced Abortion Complications Mistaken for Miscarriage in the Emergency Room Are a Risk Factor for Hospitalization.”